Literature DB >> 19797501

Technical details influence the diagnostic accuracy of the 1 microg ACTH stimulation test.

Matthew Wade1, Smita Baid, Karim Calis, Hershel Raff, Ninet Sinaii, Lynnette Nieman.   

Abstract

OBJECTIVE: To examine the factors causing inadequate cortisol responses to the 1 microg ACTH stimulation test.
DESIGN: Random test assignment (by age and gender) at 0800 or 1600 h.
METHODS: We recruited 20 healthy adults to each of the three age groups (<40 years, 40-55 years, and >55 years; half females in each group). ACTH stimulation tests were performed in an outpatient clinic at the NIH Clinical Research Center. Plasma cortisol was measured just before, and 30 and 60 min after the administration of 1 microg ACTH (1-24). The ACTH concentration in diluted and administered solutions was measured.
RESULTS: Twenty-five volunteers (19 at 1600 h) had a subnormal cortisol response (peak cortisol 10.4-17.5 microg/dl), using a criterion <18 microg/dl (497 nmol/l), for a specificity of 58% (confidence interval (CI) 45-71%). Afternoon testing had a significant impact on failure rates (odds ratio 6.98, CI 2.17-22.43), while gender and age did not. The stock solution contained 1 microg ACTH, but after administration through tubing it contained only 0.5-0.8 microg.
CONCLUSIONS: The high rate of abnormal results, especially in the afternoon, and loss of ACTH through tubing suggest that morning testing and minimal tubing should be adopted to avoid an inappropriate diagnosis of adrenal insufficiency. Earlier time points and standardized protocols would facilitate comparison of studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797501      PMCID: PMC2941345          DOI: 10.1530/EJE-09-0746

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  27 in total

Review 1.  The low dose (1 microg) ACTH stimulation test for assessment of the hypothalamo-pituitary-adrenal axis.

Authors:  A Beishuizen; J H van Lijf; J F Lekkerkerker; I Vermes
Journal:  Neth J Med       Date:  2000-03       Impact factor: 1.422

2.  Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test.

Authors:  G Dickstein; C Shechner; W E Nicholson; I Rosner; Z Shen-Orr; F Adawi; M Lahav
Journal:  J Clin Endocrinol Metab       Date:  1991-04       Impact factor: 5.958

3.  Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man.

Authors:  W Oelkers; T Boelke; V Bähr
Journal:  J Clin Endocrinol Metab       Date:  1988-01       Impact factor: 5.958

4.  Use of oral corticosteroids in the United Kingdom.

Authors:  T P van Staa; H G Leufkens; L Abenhaim; B Begaud; B Zhang; C Cooper
Journal:  QJM       Date:  2000-02

5.  Reproducibility of the cortisol response to stimulation with a low dose of ACTH(1-24): the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics.

Authors:  S Crowley; P C Hindmarsh; J W Honour; C G Brook
Journal:  J Endocrinol       Date:  1993-01       Impact factor: 4.286

Review 6.  Clinical review 62: Laboratory assessment of adrenal insufficiency.

Authors:  S K Grinspoon; B M Biller
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

7.  Use of the low-dose corticotropin stimulation test for the diagnosis of secondary adrenocortical insufficiency.

Authors:  C H Choi; S C Tiu; C C Shek; K L Choi; F K W Chan; P S Kong
Journal:  Hong Kong Med J       Date:  2002-12       Impact factor: 2.227

8.  Reproducibility of the cortisol response to stimulation with the low dose (1 microg) of ACTH.

Authors:  Y J Park; K S Park; J H Kim; C S Shin; S Y Kim; H K Lee
Journal:  Clin Endocrinol (Oxf)       Date:  1999-08       Impact factor: 3.478

9.  Measurements of serum free cortisol in critically ill patients.

Authors:  Amir H Hamrahian; Tawakalitu S Oseni; Baha M Arafah
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

Review 10.  Dynamic evaluation of adrenal hypofunction.

Authors:  L K Nieman
Journal:  J Endocrinol Invest       Date:  2003       Impact factor: 4.256

View more
  26 in total

Review 1.  Adrenal insufficiency: etiology, diagnosis and treatment.

Authors:  Nicola Neary; Lynnette Nieman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

2.  Total and free cortisol levels during 1 μg, 25 μg, and 250 μg cosyntropin stimulation tests compared to insulin tolerance test: results of a randomized, prospective, pilot study.

Authors:  Seenia Peechakara; James Bena; Nigel J Clarke; Michael J McPhaul; Richard E Reitz; Robert J Weil; Pablo Recinos; Laurence Kennedy; Amir H Hamrahian
Journal:  Endocrine       Date:  2017-07-20       Impact factor: 3.633

3.  Performance of low-dose cosyntropin stimulation test handled via plastic tube.

Authors:  Leonard Saiegh; Asala Abu-Ahmad; Mohammad Sheikh-Ahmad; Maria Reut; Limor Chen-Konak; Nizar Jiries; Carmela Shechner
Journal:  Endocrine       Date:  2017-05-22       Impact factor: 3.633

4.  Dissociation of ACTH and cortisol in septic and non-septic ICU patients.

Authors:  Hershel Raff; Nebiyu Biru; Neil Reisinger; David J Kramer
Journal:  Endocrine       Date:  2016-07-18       Impact factor: 3.633

5.  Adipsic diabetes insipidus in pediatric patients.

Authors:  Dominika Malgorzata Janus; Malgorzata Wojcik; Agata Zygmunt-Górska; Lukasz Wyrobek; Andrzej Urbanik; Jerzy Bogdan Starzyk
Journal:  Indian J Pediatr       Date:  2014-05-02       Impact factor: 1.967

Review 6.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

7.  Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasone.

Authors:  Sarita D Boyd; Colleen Hadigan; Maryellen McManus; Cheryl Chairez; Lynnette K Nieman; Alice K Pau; Raul M Alfaro; Joseph A Kovacs; Monica M Calderon; Scott R Penzak
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

8.  Partial empty sella syndrome, GH deficiency and transient central adrenal insufficiency in a patient with NF1.

Authors:  Eleni Magdalini Kyritsi; Maria Hasiotou; Christina Kanaka-Gantenbein
Journal:  Endocrine       Date:  2020-06-09       Impact factor: 3.633

9.  Prevalence of hypothalamic-pituitary-adrenal axis suppression in children treated for asthma with inhaled corticosteroid.

Authors:  Ryan W Smith; Kim Downey; Michelle Gordon; Alan Hudak; Rob Meeder; Sarah Barker; W Gary Smith
Journal:  Paediatr Child Health       Date:  2012-05       Impact factor: 2.253

10.  Measurements of serum DHEA and DHEA sulphate levels improve the accuracy of the low-dose cosyntropin test in the diagnosis of central adrenal insufficiency.

Authors:  Laure Sayyed Kassem; Katia El Sibai; Joumana Chaiban; Dima Abdelmannan; Baha M Arafah
Journal:  J Clin Endocrinol Metab       Date:  2012-07-31       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.